Apply for SP 18 003
- The Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis in the health sector is offering a public funding opportunity titled "Drug Free Communities – Competing Continuation" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.276.
- This funding opportunity was created on Jan 12, 2018.
- Applicants must submit their applications by Mar 29, 2018.
- Each selected applicant is eligible to receive up to $125,000.00 in funding.
- The number of recipients for this funding is limited to 120 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
Browse more opportunities from the same category: Health
Next opportunity: Grants to Military-Connected Local Educational Agencies for Academic and Support Programs (MCASP)
Previous opportunity: DRL Supporting Justice and Accountability Efforts in Tunisia
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.Apply for SP 18 003
Applicants also applied for:
Applicants who have applied for this opportunity (SP 18 003) also looked into and applied for these:
|Funding Number||Funding Title|
|RFA TW 18 001||African Association for Health Professions Education and Research (R25)(Clinical Trials Not Allowed)|
|RFA HS 18 001||Patient Safety Learning Laboratories: Pursuing Safety in Diagnosis and Treatment at the Intersection of Design, Systems Engineering, and Health Services Research (R18)|
|CDC RFA OT18 1804||Technical Assistance for Response to Public Health or Healthcare Crises|
|SSF75018GR||PEPFAR HIV and AIDS Community Grants|
|SM 18 020||Clinical Support System for Serious Mental Illness Funding Opportunity Announcement (FOA)|
|HRSA 18 070||Quality Improvement in Newborn Screening Program|
|RFA GH 18 002||Strengthening detection of emerging infectious diseases in India|
|RFA RM 18 016||Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed)|
|RFA RM 18 015||Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Gene Editing (U01 Clinical Trial Not Allowed)|
|RFA RM 18 012||Rodent Testing Centers for Development of Reporter Systems and Evaluation of Somatic Cell Genome Editing Tools (U42 Clinical Trial Not Allowed)|
|RFA RM 18 013||Development of Large Animal Reporter Systems for Testing Somatic Cell Genome Editing Tools (U24 Clinical Trial Not Allowed)|
|HRSA 18 048||Evidence-Informed Approaches to Improving Health Outcomes for People Living with HIV|
|HRSA 18 036||Rural Quality Improvement Technical Assistance Cooperative Agreement|
|HRSA 18 064||Vision Screening in Young Children|
|HRSA 18 082||Adolescent and Young Adult Health National Capacity Building Program|
|HRSA 18 108||Service Area Competition-Additional Areas (SAC-AA) — Newark, NJ|
|APS 72027918APS00001||H2O Yemen|
|CDC RFA OT18 1802||Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nation's Health|
|CDC RFA DP18 1803||State Public Health Approaches to Addressing Arthritis|
|PAR 18 600||Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)|
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!Apply for Grants
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "SP 18 003", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.